Report overview
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
This report aims to provide a comprehensive presentation of the global market for Cancer Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Gene Therapy. This report contains market size and forecasts of Cancer Gene Therapy in global, including the following market information:
Global Cancer Gene Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Gene Therapy market was valued at US$ 537.1 million in 2022 and is projected to reach US$ 1617.3 million by 2029, at a CAGR of 17.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Several unmet medical needs for treatment of cancer have encouraged R&D of cancer gene therapy. Various factors, such as increasing prevalence of cancer, rising government initiatives, increasing funding from various government and non-government organizations, are driving the global cancer gene therapy market. In addition, ethical acceptance of gene therapy for treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high cost involved in treatment are restraining the growth of global market for cancer gene therapy.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Gene Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Gene Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Cancer Gene Therapy Market Segment Percentages, by Type, 2022 (%)
Oncolytic Virotherapy
Gene Transfer
Gene-Induced Immunotherapy
Global Cancer Gene Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Cancer Gene Therapy Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostics Centers
Research Institutes
Global Cancer Gene Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Cancer Gene Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Gene Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Gene Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adaptimmune
Bluebird bio
Celgene
Shanghai Sunway Biotech
Shenzhen SiBiono GeneTech
SynerGene Therapeutics
Altor BioScience
Amgen
Argenx
BioCancell
GlaxoSmithKline
Merck
OncoGenex Pharmaceuticals
Transgene
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Gene Therapy, market overview.
Chapter 2: Global Cancer Gene Therapy market size in revenue.
Chapter 3: Detailed analysis of Cancer Gene Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
